CD21S antigen expression in tumour cells of diffuse large B-cell lymphomas is an independent prognostic factor indicating better overall survival

British Journal of Haematology

Volumn 125, Issue 2, 2004, Pages 180-186

  Ogawa, Shoko ^a   Yamaguchi, Motoko ^a   Oka, Kouji ^b   Taniguchi, Masanori ^c   Ito, Motohiro ^b   Nishii, Kazuhiro ^a   Nakase, Kazunori ^a   Ohno, Toshiyuki ^d   Kita, Kenkichi ^e   Kobayashi, Tohru ^a   Shiku, Hiroshi ^a  

^a MIE UNIVERSITY   (Japan)

^b Suzuka Kaisei Hospital   (Japan)

^c ISE RED CROSS HOSPITAL   (Japan)

^d Ohno Clinic   (Japan)

^e Tokura Hospital   (Japan)

Author keywords

B cells; CD21; Immunophenotype; Non Hodgkin's lymphoma; Prognostic factors

Indexed keywords

COMPLEMENT COMPONENT C3D RECEPTOR; LACTATE DEHYDROGENASE;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; B CELL LYMPHOMA; CANCER DIAGNOSIS; CANCER REGRESSION; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; FEMALE; FROZEN SECTION; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TUMOR CELL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LYMPHOMA, LARGE-CELL; MALE; MIDDLE AGED; PROGNOSIS; RECEPTORS, COMPLEMENT 3D; SURVIVAL ANALYSIS;

EID: 11144357615     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2004.04900.x     Document Type: Article

References (27)

1. Alizadeh, A.A., Eisen, M.B., Davis, R.E., Ma, C., Lossos, I.S., Rosenwald, A., Boldrick, J.C., Sabet, H., Tran, T., Yu, X., Powell, J.I., Yang, L., Marti, G.E., Moore, T., Hudson, J. Jr, Lu, L., Lewis, D.B., Tibshirani, R., Sherlock, G., Chan, W.C., Greiner, T.C., Weisenburger, D.D., Armitage, J.O., Warnke, R., Levy, R., Wilson, W., Grever, M.R., Byrd, J.C., Botstein, D., Brown, P.O. & Staudt, L.M. (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature, 403, 503-511.
2. Aubry, J.P., Pochon, S., Graber, P., Jansen, K.U. & Bonnefoy, J.Y. (1992) CD21 is a ligand for CD23 and regulates IgE production. Nature, 358, 505-507.
3. van Besien, K., Kelta, M. & Bahaguna, P. (2001) Primary mediastinal B-cell lymphoma: a review of pathology and management Journal of Clinical Oncology, 19, 1855-1854.
4. Bradbury, L.E., Kansas, G.S., Levy, S., Evans, R.L. & Tedder, T.F. (1992) The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. Journal of Immunology, 149, 2841-2850.
5. Cooper, N.R., Moore, M.D. & Nemerow, G.R. (1988) Immunobiology of CR2, the B lymphocyte receptor for Epstein-Barr virus and the C3d complement fragment. Annual Review of Immunology, 6, 85-113.
6. Cossman, J. & Jaffe, E.S. (1981) Distribution of complement receptor subtypes in non-Hodgkin's lymphomas of B-cell origin. Blood, 58, 20-26.
7. Fearon, D.T. & Carroll, M.C. (2000) Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. Annual Review of Immunology, 18, 393-422.
8. Fingeroth, J.D., Weis, J.J., Tedder, T.F., Strominger, J.L., Biro, P.A. & Fearon, D.T. (1984) Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proceedings of the National Academy of Sciences of the United Status of America, 81, 4510-4514.
9. Freedman, A.S., Boyd, A.W., Anderson, K.C., Fisher, D.C., Pinkus, G.S., Schlossman, S.F. & Nadler, L.M. (1985) Immunologic heterogeneity of diffuse large cell lymphoma. Blood, 65, 630-637.
10. Harris, N.L., Jaffe, E.S., Stein, H., Banks, P.M., Chan, J.K., Cleary, M.L., Delsol, G., De Wolf-Peeters, C., Falini, B. & Gatter, K.C. (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood, 84, 1361-1392.
11. Iida, K., Nadler, L. & Nussenzweig, V. (1983) Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody. Journal of Experimental Medicine, 158, 1021-1033.
12. Isaacson, P.G., Müller-Hermelink, H.K., Piris, M.A., Berger, F., Nathwani, B.N., Swerdlow, S.H. & Harris, N.L. (2001) Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). In: World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues (ed. by E.S. Jaffe, N.L. Harris, H. Stein & J.W. Vardiman), pp. 157-160. IARC Press, Lyon.
13. Liu, Y.J., Xu, J., de Bouteiller, O., Parham, C.L., Grouard, G., Djossou, O., de Saint-Vis, B., Lebecque, S., Banchereau, J. & Moore, K.W. (1997) Follicular dendritic cells specifically express the long CR2/CD21 isoform. Journal of Experimental Medicine, 185, 165-170.
14. Matsumoto, A.K., Kopicky-Burd, J., Carter, R.H., Tuveson, D.A., Tedder, T.F. & Fearon, D.T. (1991) Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19. Journal of Experimental Medicine, 173, 55-64.
15. Nadler, L.M., Stashenko, P., Hardy, R., van Agthoven, A., Terhorst, C. & Schlossman, S.F. (1981) Characterization of a human B cell-specific antigen (B2) distinct from B1. Journal of Immunology, 126, 1941-1947.
16. Oka, K., Ohno, T., Kita, K., Yamaguchi, M., Takakura, N., Nishii, K., Miwa, H. & Shirakawa, S. (1994) PRAD1 gene over-expression in mantle-cell lymphoma but not in other low-grade B-cell lymphomas, including extranodal lymphoma. British Journal of Haematology, 86, 786-791.
17. Schuurman, H.J., van Baarlen, J., Huppes, W., Lam, B.W., Verdonck, L.F. & van Unnik, J.A. (1987) Immunophenotyping of non-Hodgkin's lymphoma. Lack of correlation between immunophenotype and cell morphology. American Journal of Pathology, 129, 140-151.
18. Schuurman, H.J., Huppes, W., Verdonck, L.F., Van Baarlen, J. & Van Unnik, J.A. (1988) Immunophenotyping of non-Hodgkin's lymphoma. Correlation with relapse-free survival. American Journal of Pathology, 131, 102-111.
19. Scoazec, J.Y., Berger, F., Magaud, J.P., Brochier, J., Coiffier, B. & Bryon, P.A. (1989) The dendritic reticulum cell pattern in B cell lymphomas of the small cleaved, mixed, and large cell types: an immunohistochemical study of 48 cases. Human Pathology, 20, 124-131.
20. Tedder, T.F., Clement, L.T. & Cooper, M.D. (1984) Expression of C3d receptors during human B cell differentiation: immunofluorescence analysis with the HB-5 monoclonal antibody. Journal of Immunology, 133, 678-683.
21. Tedder, T.F., Zhou, L.-J. & Engel, P. (1994) The CD19/CD21 signal transduction complex of B lymphocytes. Immunology Today, 15, 437-142.
22. The International Non-Hodgkin's Lymphoma Prognostic Factors Project (1993) A predictive model for aggressive non-Hodgkin's lymphoma. New England Journal of Medicine, 329, 987-994.
23. The Non-Hodgkin's Lymphoma Classification Project (1997) A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood, 89, 3909-3918.
24. Timens, W., Boes, A. & Poppema, S. (1989a) Human marginal zone B cells are not an activated B cell subset strong expression of CD21 as a putative mediator for rapid B cell activation. European Journal of Immunology, 19, 2163-2166.
25. Timens, W., Boes, A., Rozeboom-Uiterwijk, T. & Poppema, S. (1989b) Immaturity of the human splenic marginal zone in infancy. Possible contribution to the deficient infant immune response. Journal of Immunology, 143, 3200-3206.
26. r membrane protein as the C3d receptor (CR2) of human B lymphocytes. Proceedings of the National Academy of Sciences of the United Status of America, 81, 881-885.
27. + diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients. Blood, 99, 815-821.